GEORGE J. LONGO

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ProPhase Labs, Inc.

Filing Date Source Excerpt
2002-03-26 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and Director of the Company. Mr. Longo was also appointed as a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately held international manufacturing firms and Manager of Corporate Accounting with the predecessor pharmaceutical company to Aventis S.A. (NYSE-AVE), being responsible for SEC and IRS compliance, and was involved in acquisition and general accounting issues.
2003-03-31 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo assumed his duties as Vice President and Chief Financial Officer for the Company in January 1997. Mr. Longo was also appointed as a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately held international manufacturing firms and Manager of Corporate Accounting with the predecessor pharmaceutical company to Aventis S.A. (NYSE-AVE), being responsible for SEC and IRS compliance, and was involved in acquisition and general accounting issues. Prior to that, Mr. Longo was with KPMG LLP.
2004-04-29 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo was also appointed as a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately held international manufacturing firms and Manager of Corporate Accounting with the predecessor pharmaceutical company to Aventis S.A. (NYSE-AVE), being responsible for SEC and IRS compliance, and was involved in acquisition and general accounting issues. Prior to that, Mr. Longo was with KPMG LLP.
2005-05-02 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo assumed his duties as Vice President and Chief Financial Officer for the Company in January 1997. Mr. Longo was also appointed a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately-held international manufacturing firms and in Corporate Accounting Management with the predecessor pharmaceutical company to Aventis S.A. Prior to that, Mr. Longo was with KPMG LLP.
2006-05-01 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo assumed his duties as Vice President and Chief Financial Officer for the Company in January 1997. Mr. Longo was also appointed a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately-held international manufacturing firms and in Corporate Accounting Management with the predecessor pharmaceutical company to Aventis S.A. Prior to that, Mr. Longo was with KPMG LLP.
2007-04-17 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo assumed his duties as Vice President and Chief Financial Officer for the Company in January 1997. Mr. Longo was also appointed a Director of the Company in March 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately-held international manufacturing firms, in Corporate Accounting Management with the predecessor pharmaceutical company to Aventis S.A., and was with KPMG LLP.
2008-04-04 GEORGE J. LONGO currently serves as Vice President, Chief Financial Officer and a Director of the Company. Mr. Longo assumed his duties as Vice President and Chief Financial Officer for the Company in January 1997. Before joining the Company, Mr. Longo served as Chief Financial Officer of two privately-held international manufacturing firms, in Corporate Accounting Management with the predecessor pharmaceutical company to Sanofi-aventis (NYSE-SYN), and was with KPMG LLP.

Data sourced from SEC filings. Last updated: 2025-08-30